PDF(Pubmed)
Abstract：
UNASSIGNED: To analyze the costs and medication patterns of patients with chronic kidney disease (CKD) and comorbidities in Xuzhou, China, using a large electronic medical records database.
UNASSIGNED: Data were obtained from an electronic medical records database. The annual per-person and per-visit cost of hospitalization, as well as the proportions of those costs, are presented.
UNASSIGNED: The majority of the participants were middle-aged men, and had medical insurance. Glomerulonephritis was the primary cause of CKD in patients with an identified etiology. The average per-visit cost of hospitalization for the CKD-renal anemia and CKD-mineral and bone disorder groups was 8,674.5 (5,154.3-13,949.6) and 8,182.6 (4,798.2-12,844.7) Yuan, respectively, which was greater than that of the other groups. The major expenses incurred were for diagnostics, drug usage, surgical procedures, laboratory tests and material costs.
UNASSIGNED: The substantial burden imposed by CKD with comorbidities indicates the importance of implementing public health strategies aimed at detecting and preventing these conditions in the general population. With the aging population, our nation may experience a greater CKD-related economic burden.
UNASSIGNED: Data were obtained from an electronic medical records database. The annual per-person and per-visit cost of hospitalization, as well as the proportions of those costs, are presented.
UNASSIGNED: The majority of the participants were middle-aged men, and had medical insurance. Glomerulonephritis was the primary cause of CKD in patients with an identified etiology. The average per-visit cost of hospitalization for the CKD-renal anemia and CKD-mineral and bone disorder groups was 8,674.5 (5,154.3-13,949.6) and 8,182.6 (4,798.2-12,844.7) Yuan, respectively, which was greater than that of the other groups. The major expenses incurred were for diagnostics, drug usage, surgical procedures, laboratory tests and material costs.
UNASSIGNED: The substantial burden imposed by CKD with comorbidities indicates the importance of implementing public health strategies aimed at detecting and preventing these conditions in the general population. With the aging population, our nation may experience a greater CKD-related economic burden.
摘要：
■分析徐州市慢性肾脏病(CKD)合并合并症患者的费用和用药模式,中国,使用大型电子病历数据库。
■数据来自电子病历数据库。每年每人和每次就诊的住院费用，以及这些费用的比例，被呈现。
■大多数参与者是中年男子，还有医疗保险.在病因明确的患者中，肾小球肾炎是CKD的主要原因。CKD-肾性贫血和CKD-矿物质和骨骼疾病组的平均每次住院费用为8,674.5（5,154.3-13,949.6）和8,182.6（4,798.2-12,844.7）元，分别,比其他群体更大。发生的主要费用是诊断，药物使用,外科手术,实验室测试和材料成本。
■CKD伴随合并症带来的巨大负担表明，在普通人群中实施旨在检测和预防这些疾病的公共卫生策略的重要性。随着人口老龄化,我们的国家可能会经历更大的CKD相关的经济负担。
■数据来自电子病历数据库。每年每人和每次就诊的住院费用，以及这些费用的比例，被呈现。
■大多数参与者是中年男子，还有医疗保险.在病因明确的患者中，肾小球肾炎是CKD的主要原因。CKD-肾性贫血和CKD-矿物质和骨骼疾病组的平均每次住院费用为8,674.5（5,154.3-13,949.6）和8,182.6（4,798.2-12,844.7）元，分别,比其他群体更大。发生的主要费用是诊断，药物使用,外科手术,实验室测试和材料成本。
■CKD伴随合并症带来的巨大负担表明，在普通人群中实施旨在检测和预防这些疾病的公共卫生策略的重要性。随着人口老龄化,我们的国家可能会经历更大的CKD相关的经济负担。
